Interestingly, Navab et al. [23] have recently identified a prognostic gene expression signature derived from CAFs isolated from lung cancer patients and reported that FAK and MAPK are two major intracellular signaling pathways activated in CAFs, which collectively suggest the clinical relevance of our findings. This evidence concerns the gene PTK2 and lung cancer.